DV
Dividend Vision

MIST — Milestone Pharmaceuticals Inc

Milestone Pharmaceuticals Inc (MIST)

Total return is -92.8% over the past 7.3 years, 294.2 points behind SPY at 201.4%. Its deepest 1-year drawdown was 65.8%.

MIST is a single-stock equity holding in Milestone Pharmaceuticals Inc, a pharmaceutical company. As a concentrated stock position rather than a diversified fund, it does not generate dividend distributions and carries no fund-level expense ratio, though it reflects the price volatility and operational risks of an individual biotech company. This holding may appeal to investors seeking direct exposure to Milestone Pharmaceuticals' business performance rather than those pursuing regular dividend income.

MIST key facts

Asset type
Stock
Asset class
Equity
Inception date
05/09/2019
Last close
$1.10
Market cap
$153,132,528
Average volume
2166800.0
Beta
0.971
Payout ratio
0.0
Forward P/E
0.0
EPS
$-0.67